# Effect of Nalbuphine on Hemodynamic Response During Laryngoscopy and Intubation

> **NCT07348159** · NA · COMPLETED · sponsor: **Dr. Waseem Ullah** · enrollment: 107 (actual)

## Conditions studied

- Hemodynamic Response to Laryngoscopy and Orotracheal Intubation

## Interventions

- **DRUG:** Normal saline IV
- **DRUG:** Nalbuphine 0.2 mg/kg

## Key facts

- **NCT ID:** NCT07348159
- **Lead sponsor:** Dr. Waseem Ullah
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-01
- **Primary completion:** 2024-12-15
- **Final completion:** 2024-12-15
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2026-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07348159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07348159, "Effect of Nalbuphine on Hemodynamic Response During Laryngoscopy and Intubation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07348159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*